Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View


European Medicines Agency or EMA, on Wednesday, recommended that a booster dose of Covid-19 Vaccine Janssen, developed by Janssen Pharmaceuticals, an arm of Johnson & Johnson (JNJ), may be considered at least 60 days after the first dose in individuals aged 18 years and above.


RTTNews | Dec 15, 2021 06:53AM EST

06:53 Wednesday, December 15, 2021 (RTTNews.com) - European Medicines Agency or EMA, on Wednesday, recommended that a booster dose of Covid-19 Vaccine Janssen, developed by Janssen Pharmaceuticals, an arm of Johnson & Johnson (JNJ), may be considered at least 60 days after the first dose in individuals aged 18 years and above.

EMA's move follows the latest figures which showed a rise in the presence of antibodies against SARS-CoV-2 in adults who have received a booster dose of Covid-19 Vaccine Janssen shot at least eight-week period after the first dose.

However, the risk of thrombosis in combination with thrombocytopenia (TTS) or other very rare side effects after a booster is not known and is being carefully monitored, EMA said in a statement. The agency also added that a booster dose with Covid-19 Vaccine Janssen may be given after two doses of one of the mRNA vaccines authorized in the EU- Comirnaty from Pfizer/BioNTech or Spikevax from Moderna.

Read the original article on RTTNews ( https://www.rttnews.com/3249445/ema-recommends-covid-19-vaccine-janssen-booster-shot-for-adults.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-5
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC